157 related articles for article (PubMed ID: 19118554)
1. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.
Moritoki Y; Zhang W; Tsuneyama K; Yoshida K; Wakabayashi K; Yang GX; Bowlus C; Ridgway WM; Ueno Y; Ansari AA; Coppel RL; Mackay IR; Flavell RA; Gershwin ME; Lian ZX
Gastroenterology; 2009 Mar; 136(3):1037-47. PubMed ID: 19118554
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
[TBL] [Abstract][Full Text] [Related]
4. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.
Tanaka H; Zhang W; Yang GX; Ando Y; Tomiyama T; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Lian ZX; Ridgway WM; Joh T; Gershwin ME
Clin Exp Immunol; 2014 Nov; 178(2):253-61. PubMed ID: 25041369
[TBL] [Abstract][Full Text] [Related]
5. Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis.
Zhang W; Moritoki Y; Tsuneyama K; Yang GX; Ilan Y; Lian ZX; Gershwin ME
Clin Exp Immunol; 2009 Sep; 157(3):359-64. PubMed ID: 19664143
[TBL] [Abstract][Full Text] [Related]
6. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
Moritoki Y; Lian ZX; Lindor K; Tuscano J; Tsuneyama K; Zhang W; Ueno Y; Dunn R; Kehry M; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2009 Dec; 50(6):1893-903. PubMed ID: 19877182
[TBL] [Abstract][Full Text] [Related]
7. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
[TBL] [Abstract][Full Text] [Related]
8. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
[TBL] [Abstract][Full Text] [Related]
9. Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.
Moritoki Y; Tsuneyama K; Nakamura Y; Kikuchi K; Shiota A; Ohsugi Y; Lian ZX; Zhang W; Yang GX; Ueki S; Takeda M; Omokawa A; Saga T; Saga A; Watanabe D; Miura M; Ueno Y; Leung PSC; Tanaka A; Gershwin ME; Hirokawa M
Front Immunol; 2018; 9():2534. PubMed ID: 30450101
[TBL] [Abstract][Full Text] [Related]
10. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.
Oertelt S; Lian ZX; Cheng CM; Chuang YH; Padgett KA; He XS; Ridgway WM; Ansari AA; Coppel RL; Li MO; Flavell RA; Kronenberg M; Mackay IR; Gershwin ME
J Immunol; 2006 Aug; 177(3):1655-60. PubMed ID: 16849474
[TBL] [Abstract][Full Text] [Related]
11. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.
Kennedy L; Francis H; Invernizzi P; Venter J; Wu N; Carbone M; Gershwin ME; Bernuzzi F; Franchitto A; Alvaro D; Marzioni M; Onori P; Gaudio E; Sybenga A; Fabris L; Meng F; Glaser S; Alpini G
FASEB J; 2019 Sep; 33(9):10269-10279. PubMed ID: 31251081
[TBL] [Abstract][Full Text] [Related]
12. Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.
Yang GX; Sun Y; Tsuneyama K; Zhang W; Leung PS; He XS; Ansari AA; Bowlus C; Ridgway WM; Gershwin ME
Clin Exp Immunol; 2016 Aug; 185(2):154-64. PubMed ID: 27148790
[TBL] [Abstract][Full Text] [Related]
13. Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4
Zhao ZB; Lu FT; Ma HD; Wang YH; Yang W; Long J; Miao Q; Zhang W; Tian Z; Ridgway WM; Cao J; Gershwin ME; Lian ZX
Cell Mol Immunol; 2020 Feb; 17(2):178-189. PubMed ID: 30874628
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.
Yang JB; Wang YH; Yang W; Lu FT; Ma HD; Zhao ZB; Jia YJ; Tang W; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
J Autoimmun; 2016 Jan; 66():108-17. PubMed ID: 26432598
[TBL] [Abstract][Full Text] [Related]
15. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
[TBL] [Abstract][Full Text] [Related]
16. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
[TBL] [Abstract][Full Text] [Related]
17. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
Papadakis KA; Krempski J; Reiter J; Svingen P; Xiong Y; Sarmento OF; Huseby A; Johnson AJ; Lomberk GA; Urrutia RA; Faubion WA
Am J Physiol Cell Physiol; 2015 Mar; 308(5):C362-71. PubMed ID: 25472963
[TBL] [Abstract][Full Text] [Related]
19. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
[TBL] [Abstract][Full Text] [Related]
20. Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent.
Yang CY; Leung PS; Yang GX; Kenny TP; Zhang W; Coppel R; Norman GL; Ansari AA; Mackay IR; Worman HJ; Gershwin ME
Clin Exp Immunol; 2012 Jun; 168(3):261-7. PubMed ID: 22519587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
